Global Overactive Bladder Therapeutics Market Growth (Status and Outlook) 2024-2030

May 2024 | 85 pages | ID: GE004D2259DBEN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

Overactive bladder (OAB) is a bladder disorder that results in an abnormal urge to urinate, urinary frequency, and nocturia (voiding at night). Some patients may also experience urinary incontinence (involuntary loss of bladder control). This report only focuses on the treatment drugs and Device.

The global Overactive Bladder Therapeutics market size is projected to grow from US$ 4989.1 million in 2023 to US$ 5926.3 million in 2030; it is expected to grow at a CAGR of 2.5% from 2024 to 2030.

LPI (LP Information)' newest research report, the “Overactive Bladder Therapeutics Industry Forecast” looks at past sales and reviews total world Overactive Bladder Therapeutics sales in 2023, providing a comprehensive analysis by region and market sector of projected Overactive Bladder Therapeutics sales for 2024 through 2030. With Overactive Bladder Therapeutics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Overactive Bladder Therapeutics industry.

This Insight Report provides a comprehensive analysis of the global Overactive Bladder Therapeutics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Overactive Bladder Therapeutics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Overactive Bladder Therapeutics market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Overactive Bladder Therapeutics and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Overactive Bladder Therapeutics.

Global Overactive Bladder Treatment key players include Allergan, Astellas Pharma, Pfizer, Johnson & Johnson, Medtronic, etc. Global top five manufacturers hold a share about 90%. United States is the largest market, with a share about 60%, followed by Europe, with a share about 15 percent. In terms of product, Drugs is the largest segment, with a share about 95%. And in terms of application, the largest application is Idiopathic Overactive Bladder, followed by Neurogenic Overactive Bladder.

This report presents a comprehensive overview, market shares, and growth opportunities of Overactive Bladder Therapeutics market by product type, application, key players and key regions and countries.

Segmentation by type

• Anticholinergics
• Mirabegron
• Botox

Segmentation by application

• Idiopathic Overactive Bladder
• Neurogenic Overactive Bladder

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Astellas Pharma
• Allergan
• Pfizer
• Johnson & Johnson
• Teva (Activas)

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Overactive Bladder Therapeutics Market Size 2019-2030
  2.1.2 Overactive Bladder Therapeutics Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Overactive Bladder Therapeutics Segment by Type
  2.2.1 Anticholinergics
  2.2.2 Mirabegron
  2.2.3 Botox
2.3 Overactive Bladder Therapeutics Market Size by Type
  2.3.1 Overactive Bladder Therapeutics Market Size CAGR by Type (2019 VS 2023 VS 2030)
  2.3.2 Global Overactive Bladder Therapeutics Market Size Market Share by Type (2019-2024)
2.4 Overactive Bladder Therapeutics Segment by Application
  2.4.1 Idiopathic Overactive Bladder
  2.4.2 Neurogenic Overactive Bladder
2.5 Overactive Bladder Therapeutics Market Size by Application
  2.5.1 Overactive Bladder Therapeutics Market Size CAGR by Application (2019 VS 2023 VS 2030)
  2.5.2 Global Overactive Bladder Therapeutics Market Size Market Share by Application (2019-2024)

3 OVERACTIVE BLADDER THERAPEUTICS MARKET SIZE BY PLAYER

3.1 Overactive Bladder Therapeutics Market Size Market Share by Players
  3.1.1 Global Overactive Bladder Therapeutics Revenue by Players (2019-2024)
  3.1.2 Global Overactive Bladder Therapeutics Revenue Market Share by Players (2019-2024)
3.2 Global Overactive Bladder Therapeutics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 OVERACTIVE BLADDER THERAPEUTICS BY REGIONS

4.1 Overactive Bladder Therapeutics Market Size by Regions (2019-2024)
4.2 Americas Overactive Bladder Therapeutics Market Size Growth (2019-2024)
4.3 APAC Overactive Bladder Therapeutics Market Size Growth (2019-2024)
4.4 Europe Overactive Bladder Therapeutics Market Size Growth (2019-2024)
4.5 Middle East & Africa Overactive Bladder Therapeutics Market Size Growth (2019-2024)

5 AMERICAS

5.1 Americas Overactive Bladder Therapeutics Market Size by Country (2019-2024)
5.2 Americas Overactive Bladder Therapeutics Market Size by Type (2019-2024)
5.3 Americas Overactive Bladder Therapeutics Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Overactive Bladder Therapeutics Market Size by Region (2019-2024)
6.2 APAC Overactive Bladder Therapeutics Market Size by Type (2019-2024)
6.3 APAC Overactive Bladder Therapeutics Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Overactive Bladder Therapeutics by Country (2019-2024)
7.2 Europe Overactive Bladder Therapeutics Market Size by Type (2019-2024)
7.3 Europe Overactive Bladder Therapeutics Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Overactive Bladder Therapeutics by Region (2019-2024)
8.2 Middle East & Africa Overactive Bladder Therapeutics Market Size by Type (2019-2024)
8.3 Middle East & Africa Overactive Bladder Therapeutics Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL OVERACTIVE BLADDER THERAPEUTICS MARKET FORECAST

10.1 Global Overactive Bladder Therapeutics Forecast by Regions (2025-2030)
  10.1.1 Global Overactive Bladder Therapeutics Forecast by Regions (2025-2030)
  10.1.2 Americas Overactive Bladder Therapeutics Forecast
  10.1.3 APAC Overactive Bladder Therapeutics Forecast
  10.1.4 Europe Overactive Bladder Therapeutics Forecast
  10.1.5 Middle East & Africa Overactive Bladder Therapeutics Forecast
10.2 Americas Overactive Bladder Therapeutics Forecast by Country (2025-2030)
  10.2.1 United States Overactive Bladder Therapeutics Market Forecast
  10.2.2 Canada Overactive Bladder Therapeutics Market Forecast
  10.2.3 Mexico Overactive Bladder Therapeutics Market Forecast
  10.2.4 Brazil Overactive Bladder Therapeutics Market Forecast
10.3 APAC Overactive Bladder Therapeutics Forecast by Region (2025-2030)
  10.3.1 China Overactive Bladder Therapeutics Market Forecast
  10.3.2 Japan Overactive Bladder Therapeutics Market Forecast
  10.3.3 Korea Overactive Bladder Therapeutics Market Forecast
  10.3.4 Southeast Asia Overactive Bladder Therapeutics Market Forecast
  10.3.5 India Overactive Bladder Therapeutics Market Forecast
  10.3.6 Australia Overactive Bladder Therapeutics Market Forecast
10.4 Europe Overactive Bladder Therapeutics Forecast by Country (2025-2030)
  10.4.1 Germany Overactive Bladder Therapeutics Market Forecast
  10.4.2 France Overactive Bladder Therapeutics Market Forecast
  10.4.3 UK Overactive Bladder Therapeutics Market Forecast
  10.4.4 Italy Overactive Bladder Therapeutics Market Forecast
  10.4.5 Russia Overactive Bladder Therapeutics Market Forecast
10.5 Middle East & Africa Overactive Bladder Therapeutics Forecast by Region (2025-2030)
  10.5.1 Egypt Overactive Bladder Therapeutics Market Forecast
  10.5.2 South Africa Overactive Bladder Therapeutics Market Forecast
  10.5.3 Israel Overactive Bladder Therapeutics Market Forecast
  10.5.4 Turkey Overactive Bladder Therapeutics Market Forecast
  10.5.5 GCC Countries Overactive Bladder Therapeutics Market Forecast
10.6 Global Overactive Bladder Therapeutics Forecast by Type (2025-2030)
10.7 Global Overactive Bladder Therapeutics Forecast by Application (2025-2030)

11 KEY PLAYERS ANALYSIS

11.1 Astellas Pharma
  11.1.1 Astellas Pharma Company Information
  11.1.2 Astellas Pharma Overactive Bladder Therapeutics Product Offered
  11.1.3 Astellas Pharma Overactive Bladder Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
  11.1.4 Astellas Pharma Main Business Overview
  11.1.5 Astellas Pharma Latest Developments
11.2 Allergan
  11.2.1 Allergan Company Information
  11.2.2 Allergan Overactive Bladder Therapeutics Product Offered
  11.2.3 Allergan Overactive Bladder Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
  11.2.4 Allergan Main Business Overview
  11.2.5 Allergan Latest Developments
11.3 Pfizer
  11.3.1 Pfizer Company Information
  11.3.2 Pfizer Overactive Bladder Therapeutics Product Offered
  11.3.3 Pfizer Overactive Bladder Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
  11.3.4 Pfizer Main Business Overview
  11.3.5 Pfizer Latest Developments
11.4 Johnson & Johnson
  11.4.1 Johnson & Johnson Company Information
  11.4.2 Johnson & Johnson Overactive Bladder Therapeutics Product Offered
  11.4.3 Johnson & Johnson Overactive Bladder Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
  11.4.4 Johnson & Johnson Main Business Overview
  11.4.5 Johnson & Johnson Latest Developments
11.5 Teva (Activas)
  11.5.1 Teva (Activas) Company Information
  11.5.2 Teva (Activas) Overactive Bladder Therapeutics Product Offered
  11.5.3 Teva (Activas) Overactive Bladder Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
  11.5.4 Teva (Activas) Main Business Overview
  11.5.5 Teva (Activas) Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Overactive Bladder Therapeutics Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Anticholinergics
Table 3. Major Players of Mirabegron
Table 4. Major Players of Botox
Table 5. Overactive Bladder Therapeutics Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 6. Global Overactive Bladder Therapeutics Market Size by Type (2019-2024) & ($ Millions)
Table 7. Global Overactive Bladder Therapeutics Market Size Market Share by Type (2019-2024)
Table 8. Overactive Bladder Therapeutics Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 9. Global Overactive Bladder Therapeutics Market Size by Application (2019-2024) & ($ Millions)
Table 10. Global Overactive Bladder Therapeutics Market Size Market Share by Application (2019-2024)
Table 11. Global Overactive Bladder Therapeutics Revenue by Players (2019-2024) & ($ Millions)
Table 12. Global Overactive Bladder Therapeutics Revenue Market Share by Player (2019-2024)
Table 13. Overactive Bladder Therapeutics Key Players Head office and Products Offered
Table 14. Overactive Bladder Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Overactive Bladder Therapeutics Market Size by Regions 2019-2024 & ($ Millions)
Table 18. Global Overactive Bladder Therapeutics Market Size Market Share by Regions (2019-2024)
Table 19. Global Overactive Bladder Therapeutics Revenue by Country/Region (2019-2024) & ($ millions)
Table 20. Global Overactive Bladder Therapeutics Revenue Market Share by Country/Region (2019-2024)
Table 21. Americas Overactive Bladder Therapeutics Market Size by Country (2019-2024) & ($ Millions)
Table 22. Americas Overactive Bladder Therapeutics Market Size Market Share by Country (2019-2024)
Table 23. Americas Overactive Bladder Therapeutics Market Size by Type (2019-2024) & ($ Millions)
Table 24. Americas Overactive Bladder Therapeutics Market Size Market Share by Type (2019-2024)
Table 25. Americas Overactive Bladder Therapeutics Market Size by Application (2019-2024) & ($ Millions)
Table 26. Americas Overactive Bladder Therapeutics Market Size Market Share by Application (2019-2024)
Table 27. APAC Overactive Bladder Therapeutics Market Size by Region (2019-2024) & ($ Millions)
Table 28. APAC Overactive Bladder Therapeutics Market Size Market Share by Region (2019-2024)
Table 29. APAC Overactive Bladder Therapeutics Market Size by Type (2019-2024) & ($ Millions)
Table 30. APAC Overactive Bladder Therapeutics Market Size Market Share by Type (2019-2024)
Table 31. APAC Overactive Bladder Therapeutics Market Size by Application (2019-2024) & ($ Millions)
Table 32. APAC Overactive Bladder Therapeutics Market Size Market Share by Application (2019-2024)
Table 33. Europe Overactive Bladder Therapeutics Market Size by Country (2019-2024) & ($ Millions)
Table 34. Europe Overactive Bladder Therapeutics Market Size Market Share by Country (2019-2024)
Table 35. Europe Overactive Bladder Therapeutics Market Size by Type (2019-2024) & ($ Millions)
Table 36. Europe Overactive Bladder Therapeutics Market Size Market Share by Type (2019-2024)
Table 37. Europe Overactive Bladder Therapeutics Market Size by Application (2019-2024) & ($ Millions)
Table 38. Europe Overactive Bladder Therapeutics Market Size Market Share by Application (2019-2024)
Table 39. Middle East & Africa Overactive Bladder Therapeutics Market Size by Region (2019-2024) & ($ Millions)
Table 40. Middle East & Africa Overactive Bladder Therapeutics Market Size Market Share by Region (2019-2024)
Table 41. Middle East & Africa Overactive Bladder Therapeutics Market Size by Type (2019-2024) & ($ Millions)
Table 42. Middle East & Africa Overactive Bladder Therapeutics Market Size Market Share by Type (2019-2024)
Table 43. Middle East & Africa Overactive Bladder Therapeutics Market Size by Application (2019-2024) & ($ Millions)
Table 44. Middle East & Africa Overactive Bladder Therapeutics Market Size Market Share by Application (2019-2024)
Table 45. Key Market Drivers & Growth Opportunities of Overactive Bladder Therapeutics
Table 46. Key Market Challenges & Risks of Overactive Bladder Therapeutics
Table 47. Key Industry Trends of Overactive Bladder Therapeutics
Table 48. Global Overactive Bladder Therapeutics Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 49. Global Overactive Bladder Therapeutics Market Size Market Share Forecast by Regions (2025-2030)
Table 50. Global Overactive Bladder Therapeutics Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 51. Global Overactive Bladder Therapeutics Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 52. Astellas Pharma Details, Company Type, Overactive Bladder Therapeutics Area Served and Its Competitors
Table 53. Astellas Pharma Overactive Bladder Therapeutics Product Offered
Table 54. Astellas Pharma Overactive Bladder Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 55. Astellas Pharma Main Business
Table 56. Astellas Pharma Latest Developments
Table 57. Allergan Details, Company Type, Overactive Bladder Therapeutics Area Served and Its Competitors
Table 58. Allergan Overactive Bladder Therapeutics Product Offered
Table 59. Allergan Main Business
Table 60. Allergan Overactive Bladder Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 61. Allergan Latest Developments
Table 62. Pfizer Details, Company Type, Overactive Bladder Therapeutics Area Served and Its Competitors
Table 63. Pfizer Overactive Bladder Therapeutics Product Offered
Table 64. Pfizer Main Business
Table 65. Pfizer Overactive Bladder Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 66. Pfizer Latest Developments
Table 67. Johnson & Johnson Details, Company Type, Overactive Bladder Therapeutics Area Served and Its Competitors
Table 68. Johnson & Johnson Overactive Bladder Therapeutics Product Offered
Table 69. Johnson & Johnson Main Business
Table 70. Johnson & Johnson Overactive Bladder Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 71. Johnson & Johnson Latest Developments
Table 72. Teva (Activas) Details, Company Type, Overactive Bladder Therapeutics Area Served and Its Competitors
Table 73. Teva (Activas) Overactive Bladder Therapeutics Product Offered
Table 74. Teva (Activas) Main Business
Table 75. Teva (Activas) Overactive Bladder Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 76. Teva (Activas) Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Overactive Bladder Therapeutics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Overactive Bladder Therapeutics Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Overactive Bladder Therapeutics Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Overactive Bladder Therapeutics Sales Market Share by Country/Region (2023)
Figure 8. Overactive Bladder Therapeutics Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Overactive Bladder Therapeutics Market Size Market Share by Type in 2023
Figure 10. Overactive Bladder Therapeutics in Idiopathic Overactive Bladder
Figure 11. Global Overactive Bladder Therapeutics Market: Idiopathic Overactive Bladder (2019-2024) & ($ Millions)
Figure 12. Overactive Bladder Therapeutics in Neurogenic Overactive Bladder
Figure 13. Global Overactive Bladder Therapeutics Market: Neurogenic Overactive Bladder (2019-2024) & ($ Millions)
Figure 14. Global Overactive Bladder Therapeutics Market Size Market Share by Application in 2023
Figure 15. Global Overactive Bladder Therapeutics Revenue Market Share by Player in 2023
Figure 16. Global Overactive Bladder Therapeutics Market Size Market Share by Regions (2019-2024)
Figure 17. Americas Overactive Bladder Therapeutics Market Size 2019-2024 ($ Millions)
Figure 18. APAC Overactive Bladder Therapeutics Market Size 2019-2024 ($ Millions)
Figure 19. Europe Overactive Bladder Therapeutics Market Size 2019-2024 ($ Millions)
Figure 20. Middle East & Africa Overactive Bladder Therapeutics Market Size 2019-2024 ($ Millions)
Figure 21. Americas Overactive Bladder Therapeutics Value Market Share by Country in 2023
Figure 22. United States Overactive Bladder Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 23. Canada Overactive Bladder Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 24. Mexico Overactive Bladder Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 25. Brazil Overactive Bladder Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 26. APAC Overactive Bladder Therapeutics Market Size Market Share by Region in 2023
Figure 27. APAC Overactive Bladder Therapeutics Market Size Market Share by Type in 2023
Figure 28. APAC Overactive Bladder Therapeutics Market Size Market Share by Application in 2023
Figure 29. China Overactive Bladder Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 30. Japan Overactive Bladder Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 31. Korea Overactive Bladder Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 32. Southeast Asia Overactive Bladder Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 33. India Overactive Bladder Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 34. Australia Overactive Bladder Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 35. Europe Overactive Bladder Therapeutics Market Size Market Share by Country in 2023
Figure 36. Europe Overactive Bladder Therapeutics Market Size Market Share by Type (2019-2024)
Figure 37. Europe Overactive Bladder Therapeutics Market Size Market Share by Application (2019-2024)
Figure 38. Germany Overactive Bladder Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 39. France Overactive Bladder Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 40. UK Overactive Bladder Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 41. Italy Overactive Bladder Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 42. Russia Overactive Bladder Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 43. Middle East & Africa Overactive Bladder Therapeutics Market Size Market Share by Region (2019-2024)
Figure 44. Middle East & Africa Overactive Bladder Therapeutics Market Size Market Share by Type (2019-2024)
Figure 45. Middle East & Africa Overactive Bladder Therapeutics Market Size Market Share by Application (2019-2024)
Figure 46. Egypt Overactive Bladder Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 47. South Africa Overactive Bladder Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 48. Israel Overactive Bladder Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 49. Turkey Overactive Bladder Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 50. GCC Country Overactive Bladder Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 51. Americas Overactive Bladder Therapeutics Market Size 2025-2030 ($ Millions)
Figure 52. APAC Overactive Bladder Therapeutics Market Size 2025-2030 ($ Millions)
Figure 53. Europe Overactive Bladder Therapeutics Market Size 2025-2030 ($ Millions)
Figure 54. Middle East & Africa Overactive Bladder Therapeutics Market Size 2025-2030 ($ Millions)
Figure 55. United States Overactive Bladder Therapeutics Market Size 2025-2030 ($ Millions)
Figure 56. Canada Overactive Bladder Therapeutics Market Size 2025-2030 ($ Millions)
Figure 57. Mexico Overactive Bladder Therapeutics Market Size 2025-2030 ($ Millions)
Figure 58. Brazil Overactive Bladder Therapeutics Market Size 2025-2030 ($ Millions)
Figure 59. China Overactive Bladder Therapeutics Market Size 2025-2030 ($ Millions)
Figure 60. Japan Overactive Bladder Therapeutics Market Size 2025-2030 ($ Millions)
Figure 61. Korea Overactive Bladder Therapeutics Market Size 2025-2030 ($ Millions)
Figure 62. Southeast Asia Overactive Bladder Therapeutics Market Size 2025-2030 ($ Millions)
Figure 63. India Overactive Bladder Therapeutics Market Size 2025-2030 ($ Millions)
Figure 64. Australia Overactive Bladder Therapeutics Market Size 2025-2030 ($ Millions)
Figure 65. Germany Overactive Bladder Therapeutics Market Size 2025-2030 ($ Millions)
Figure 66. France Overactive Bladder Therapeutics Market Size 2025-2030 ($ Millions)
Figure 67. UK Overactive Bladder Therapeutics Market Size 2025-2030 ($ Millions)
Figure 68. Italy Overactive Bladder Therapeutics Market Size 2025-2030 ($ Millions)
Figure 69. Russia Overactive Bladder Therapeutics Market Size 2025-2030 ($ Millions)
Figure 70. Spain Overactive Bladder Therapeutics Market Size 2025-2030 ($ Millions)
Figure 71. Egypt Overactive Bladder Therapeutics Market Size 2025-2030 ($ Millions)
Figure 72. South Africa Overactive Bladder Therapeutics Market Size 2025-2030 ($ Millions)
Figure 73. Israel Overactive Bladder Therapeutics Market Size 2025-2030 ($ Millions)
Figure 74. Turkey Overactive Bladder Therapeutics Market Size 2025-2030 ($ Millions)
Figure 75. GCC Countries Overactive Bladder Therapeutics Market Size 2025-2030 ($ Millions)
Figure 76. Global Overactive Bladder Therapeutics Market Size Market Share Forecast by Type (2025-2030)
Figure 77. Global Overactive Bladder Therapeutics Market Size Market Share Forecast by Application (2025-2030)